Integra Lifesciences Holdings (IART) Other financing activities (2009 - 2025)

Integra Lifesciences Holdings has disclosed Other financing activities across 17 years of filings, most recently posting $957000.0 for Q1 2025.

• In Q1 2025, Other financing activities fell 85.04% year-over-year to $957000.0; the TTM figure through Dec 2025 stood at $957000.0 (down 85.04% YoY), while the FY2025 annual figure was $957000.0, down 85.04% from the prior year.
• Other financing activities came in at $957000.0 for Q1 2025 at Integra Lifesciences Holdings, down from $6.4 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $6.4 million in Q1 2024 to a low of $225000.0 in Q4 2023.
• Average Other financing activities over 5 years is $1.8 million, with a median of $1.2 million recorded in 2022.
• The largest YoY upside for Other financing activities was 138000.0% in 2021 against a maximum downside of 95.01% in 2021.
• Over 5 years, Other financing activities stood at $236000.0 in 2021, then jumped by 1541.1% to $3.9 million in 2022, then sank by 94.19% to $225000.0 in 2023, then surged by 2743.56% to $6.4 million in 2024, then sank by 85.04% to $957000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $957000.0 in Q1 2025, $6.4 million in Q1 2024, and $225000.0 in Q4 2023.